Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha
about
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinasesRelationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the ratPlatelet-activating factor: receptors and signal transductionTransit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivoPlatelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis.Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta.Thrombotic thrombocytopenic purpura associated with the acquired immune deficiency syndrome.Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shockIn vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the ratDivergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venulesNovel role for aldose reductase in mediating acute inflammatory responses in the lung.Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells.Contrasting roles for tumor necrosis factor in the pathogeneses of IgA and IgG immune complex lung injuryVascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactionsTumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endotheliumMiddle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase.Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reactionInvolvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.Blood levels of PAF are elevated during induction of immune complex mediated enteropathy in the rat.An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo.Endothelial activation and dysfunction in the pathogenesis of influenza A virus infectionHepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.In vivo antitumor mechanism of natural human tumor necrosis factor involving a T cell-mediated immunological route.15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endotheliumMetabolic effects of platelet-activating factor in rats in vivo. Stimulation of hepatic glycogenolysis and lipogenesis
P2860
Q24682349-FB8ACF34-3F1B-4C3E-AB2B-F31B099775EEQ28567302-4BF1605B-F2EC-4970-AFBD-F998FADDE9BBQ28609556-4DFCCCCF-1F55-4661-906F-E0BA3E4DB481Q30448792-1B417D3F-0A69-4A91-9C00-7A5C940C6622Q30451187-30613E32-D7CC-4E04-8573-57BFB89C15E0Q30453723-FA9F7082-F2D7-426D-BFE4-5032ACC5CB9FQ33400427-1D82DF8F-83F2-430D-BBF1-7AF11C18AC27Q33620607-A3D092B4-53A4-4480-8E60-650E39422BA3Q33749579-A811866F-638E-46DB-9EB9-736367E7EF3BQ34581136-EA76B849-21EF-4093-9F44-6DB22CEE1360Q35044815-AEF1AD20-7657-4280-96BF-DF6F06DD68B5Q35130806-A71623B4-B5A9-4BC5-8D04-8A14B6B6E603Q35598961-1241BC35-CC5A-4A39-8852-C0E9B9BA95C2Q35752847-D8F31C47-873C-475D-9682-B9B981A4EA44Q35787004-872E53F6-448F-474B-ACF2-9260B3BA003FQ35831044-DC4D189F-C74D-4FAE-B9DA-E8CCA900CD95Q36014743-1E375B2C-F1FD-4489-B3C4-F38BF2188821Q36222548-B544FDA5-87AE-47B4-BFAF-0F72CD56E939Q36350691-914A9559-D821-43E0-8BB9-83FE1E74EFCAQ36351266-3EC67624-1021-43B0-ACE9-EF0E3F704A83Q36364302-B72B1767-F8A6-47F8-A2BC-517DC66E78B4Q36376655-3C2CCFC1-7864-4743-BA4A-361200172E84Q36569348-B2147B83-0D61-4E97-B01A-A45A00090ED3Q36627011-448C32EE-1D59-4E0C-936E-8A06B3068A64Q36869275-660CD091-034E-46B4-90CD-3E36B9776502Q38122282-917AD1C4-1A49-4172-9A8A-1D01B4029BAAQ41596252-558588F8-DF17-4C29-8C64-D8813D79364BQ41760588-718126E1-AD78-484E-876A-467A2488E72FQ42749168-B7400F10-D16C-499E-A34C-BF6EA65E072BQ42794668-1D81D498-720C-4618-BCE6-BBC3A7BED0D2
P2860
Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im August 1988 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1988
@uk
name
Synthesis and release of plate ...... factor or interleukin 1 alpha
@en
Synthesis and release of plate ...... factor or interleukin 1 alpha
@nl
type
label
Synthesis and release of plate ...... factor or interleukin 1 alpha
@en
Synthesis and release of plate ...... factor or interleukin 1 alpha
@nl
prefLabel
Synthesis and release of plate ...... factor or interleukin 1 alpha
@en
Synthesis and release of plate ...... factor or interleukin 1 alpha
@nl
P1476
Synthesis and release of plate ...... factor or interleukin 1 alpha
@en
P2093
Baglioni C
Bussolino F
P304
11856-11861
P407
P577
1988-08-01T00:00:00Z